Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc Conference

September 26, 2022

https://www.globenewswire.com/news-release/2022/09/26/2522476/30446/en/Aravive-to-Participate-in-the-Cantor-Fitzgerald-Oncology-HemOnc-Conference.html

HOUSTON, Sept. 26, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq:ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer and Rudy Howard, Chief Financial Officer will participate in the Cantor Fitzgerald Oncology & HemOnc Conference on September 28, 2022 at the Lotte New York Palace Hotel, New York, N.Y.

Read more at globenewswire.com

Related news for (ARAV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.